References
- Abraham BP, Mehta S, El-Serag HB. (2012). Natural history of pediatric-onset inflammatory bowel disease. J Clin Gastroenterol, 46, 581–9
- Abraham C, Cho JH. (2009). Inflammatory bowel disease. N Engl J Med, 361, 2066–78
- Adams SM, Bornemann PH. (2013). Ulcerative colitis. Am Fam Physician, 87, 699–705
- Agostini L, Martinon F, Burns K, et al. (2004). NALP3 forms an IL-1beta processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity, 20, 319–25
- Anderson CA, Boucher G, Lees CW, et al. (2011). Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet, 43, 246–52
- Bagnall RD, Roberts RG, Mirza MM, et al. (2008). Novel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutation. Eur J Hum Genet, 16, 619--25
- Bouchier-Hayes L, Conroy H, Egan H, et al. (2001). CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways. J Biol Chem, 276, 44069–77
- Bouma G, Strober W. (2003). The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol, 3, 521–33
- Büning C, Schmidt HH, Molnár T, et al. (2008). No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohorts. Inflamm Bowel Dis, 14, 332–7
- Egger M, Davey Smith G, Schneider M, et al. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629–34
- Fisher SA, Mirza MM, Onnie CM, et al. (2007). Combined evidence from three large British Association studies rejects TUCAN/CARD8 as an IBD susceptibility gene. Gastroenterology, 132, 2078–80
- Fontalba A, Gutiérrez O, Llorca J, Mateo I, et al. (2008). Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women. Dement Geriatr Cogn Disord, 26, 247–50
- Fontalba A, Martinez-Taboada V, Gutierrez O, et al. (2007). Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity. J Immunol, 179, 4867–73
- Franchimont D, Vermeire S, El Housni H, et al. (2004). Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut, 53, 987–92
- Franke A, McGovern DP, Barrett JC, et al. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet, 42, 1118–25
- Franke A, Rosenstiel P, Balschun T, et al. (2007). No association between the TUCAN (CARD8) Cys10Stop mutation and inflammatory bowel disease in a large retrospective German and a clinically well-characterized Norwegian sample. Gastroenterology, 132, 2080–1
- Geboes K, Van Eyken P. (2009). Inflammatory bowel disease unclassified and indeterminate colitis: the role of the pathologist. J Clin Pathol, 62, 201–5
- Glas J, Endres I, Tonenchi L, et al. (2009). Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Am J Gastroenterol, 104, 1723–33
- Halfvarson J. (2011). Genetics in twins with Crohn’s disease: less pronounced than previously believed? Inflamm Bowel Dis, 17, 6–12
- Hedrick TL, Friel CM. (2013). Colonic Crohn disease. Clin Colon Rectal Surg, 26(2), 84–9
- Henckaerts L, Pierik M, Joossens M, et al. (2007). Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut, 56, 1536–42
- Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539–58
- Hugot JP, Chamaillard M, Zouali H, et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature, 411, 599–603
- Kastbom A, Klingberg E, Verma D, et al. (2013). Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis. Scand J Rheumatol, 42, 465–8
- Khor B, Gardet A, Xavier RJ. (2011). Genetics and pathogenesis of inflammatory bowel disease. Nature, 474, 307–17
- Ko DC, Shukla KP, Fong C, et al. (2009). A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease. Am J Hum Genet, 85, 214–27
- McGovern DP, Butler H, Ahmad T, et al. (2006). TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology, 131, 1190–6
- McGovern DP, Hysi P, Ahmad T, et al. (2005). Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet, 14, 1245–50
- Ogura Y, Bonen DK, Inohara N, et al. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature, 411, 603–6
- Pathan N, Marusawa H, Krajewska M, et al. (2001). TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. J Biol Chem, 276, 32220–9
- Razmara M, Srinivasula SM, Wang L, et al. (2002). CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J Biol Chem, 277, 13952–8
- Roberts RL, Topless RK, Phipps-Green AJ, et al. (2010). Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun, 11, 351–6
- Schoultz I, Verma D, Halfvarsson J, et al. (2009). Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol, 104, 1180–8
- Stilo R, Leonardi A, Formisano L, et al. (2002). TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. FEBS Lett, 521, 165–9
- Thompson NP, Driscoll R, Pounder RE, et al. (1996). Genetics versus environment in inflammatory bowel disease: results of a British twin study. Br Med J, 312, 95–6
- Von Kampen O, Lipinski S, Till A, et al. (2010). Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2-mediated signaling. J Biol Chem, 285, 19921–6
- Xavier RJ, Podolsky DK. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448, 427–34
- Yamamoto M, Torigoe T, Kamiguchi K, et al. (2005). A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis. Cancer Res, 65, 8706–14
- Yang SK, Kim H, Hong M, et al. (2011). Association of CARD8 with inflammatory bowel disease in Koreans. J Hum Genet, 56, 217–23